ASQ Section 509
Washington, DC and Maryland Metro
General Membership Meeting
Presents
"Unmasking COVID Controversies"
By
Milton L. Greenberg, PhD.
Thursday, August 20, 2020
Important Notice: In light of the growing spread of COVID-19 (coronavirus) ASQ is recommending that all live events and meetings be converted to virtual formats until further notice. With that said, this meeting will be virtual. Dial in information will be send to all registrants prior to the meeting.
Summary:
Milton L. Greenberg, Ph.D. is an Assistant Adjunct Professor in the Department of Physiology and Biophysics at the University of California, Irvine, School of Medicine. Dr. Greenberg serves as the lead lecturer and course coordinator for Medical Physiology and Medical Immunology for first-year medical students. Dr. Greenberg is the co-founder and CEO of Vivreon Biosciences, a preclinical stage pharmaceutical company developing first-in-class therapeutics for chronic inflammatory diseases. He is Principle Investigator on research grant awards funded by the National Institute on Aging, National Cancer Institute, National Institute of Allergy and Infectious Disease, Alzheimer’s Drug Discovery Foundation, Michael J. Fox Foundation, and Johnson and Johnson Innovation.
Dr. Greenberg received his bachelor’s degree in biochemistry at the University of Maryland, Baltimore County, where he trained under Dr. Sergei Atamas at the University of Maryland Medical Center. Dr. Greenberg received his Ph.D. in Biomedical Sciences from the University of California, Irvine School of Medicine with a focus in immunology and biophysics in the laboratory of Dr. Michael Cahalan.
Contact information will be provided upon request. The presentation will provide an overview of Covid-19 topics to further educate our members during these quickly changing and difficult times. Specific areas that will be addressed include:
Presentation Overview:
The presentation will provide an overview of Covid-19 topics to further educate our members during these quickly changing and difficult times. Specific areas that will be addressed include:
-Status of the pandemic
-COVID transmission
-COVID testing
-COVID antibodies
-COVID therapeutics
Agenda:
General Announcements and Introductions: 6:30 p.m.
Program: 6:45 p.m.
Q&A: 7:30 p.m.
Member Employment Opportunities 8:00 p.m.
Adjourn 8:30 p.m.
We look forward to seeing you!
